US Stock MarketDetailed Quotes
CARM Carisma Therapeutics
- 0.913
- +0.012+1.31%
Trading Aug 9 14:28 ET
37.92MMarket Cap-523P/E (TTM)
0.930High0.901Low123.74KVolume0.920Open0.901Pre Close113.41KTurnover0.55%Turnover RatioLossP/E (Static)41.54MShares7.14452wk High101.42P/B20.55MFloat Cap0.80052wk Low--Dividend TTM22.51MShs Float51.357Historical High--Div YieldTTM3.22%Amplitude0.800Historical Low0.916Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
Carisma Therapeutics Stock Forum
$Cosmos Health (COSM.US)$ $African Agriculture (AAGR.US)$ $Innovative Eyewear (LUCY.US)$ $Carisma Therapeutics (CARM.US)$ $Ocean Power Technologies (OPTT.US)$
📊⚡️📊
Carisma Therapeutics Announces Nomination of First In Vivo CAR-M Development Candidate for Hepatocellular Carcinoma Under Collaboration with Moderna
Carisma Therapeutics (Nasdaq: CARM) has announced the nomination of the first in vivo CAR-M development candidate, targeting Glypican-3 (GPC3), under its collaboration with Moderna. This candidate is designed to treat solid tumors, including hepatocellular carcinoma (HCC), the fastest-rising cause of cancer-relate...
Carisma Therapeutics Granted FDA Fast Track Designation for Ct-0525 for the Treatment of Her2-Overexpressing Solid Tumors
No comment yet